Analysis of the key themes driving private equity deal activity reveals that precision and personalized medicine accounted for 2 pharmaceutical deals announced in Q2 2023, worth a total value of $11.1m. The $10m investment by Lincoln Park Capital Fund in Eterna Therapeutics was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q2 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q2 2023 â€“ Thematic Intelligence, buy the report here.